0000950170-25-034070.txt : 20250305 0000950170-25-034070.hdr.sgml : 20250305 20250305202308 ACCESSION NUMBER: 0000950170-25-034070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250303 FILED AS OF DATE: 20250305 DATE AS OF CHANGE: 20250305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benjamin Richard J CENTRAL INDEX KEY: 0001296322 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 25713260 MAIL ADDRESS: STREET 1: 15 WHITE PINE ROAD CITY: NEWTON STATE: MA ZIP: 02464 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 ownership.xml 4 X0508 4 2025-03-03 0001020214 CERUS CORP CERS 0001296322 Benjamin Richard J C/O CERUS CORPORATION 1220 CONCORD AVE SUITE 600 CONCORD CA 94520 false true false false Chief Medical Officer true Common Stock 2025-03-03 4 M false 13912 A 451919 D Common Stock 2025-03-03 4 S false 51254 1.577 D 400665 D Common Stock 2025-03-04 4 S false 6292 1.5485 D 394373 D Restricted Stock Unit 2025-03-03 4 M false 13912 D Common Stock 13912 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.525 to $1.67 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.49 to $1.59 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. Not applicable. Richard J. Benjamin, by Chrystal N. Jensen, attorney-in-fact 2025-03-05